Moore Vogel Lab

About Moore Vogel Lab

The Moore Vogel Lab at Scripps Research is dedicated to reimagining clinical research and translational medicine. We accelerate breakthroughs for complex illnesses through innovative study designs and digital technologies; empower participants via decentralized or fully remote trials, using wearable sensors, and at‑home biospecimen collection; advance health equity by ensuring diverse communities are represented; and translate science into solutions that improve lives. At the intersection of genomics, precision medicine, and digital health, we bring research innovations closer to people, and people closer to better health. Current flagship studies Long COVID Treatment Trial (LoCITT) A portfolio of fully remote randomized trials evaluating novel therapies for Long COVID, with options for at‑home biospecimen collection and digital monitoring. https://longcovid.scripps.edu/ Long COVID Wearable Study (LCW) Validating wearable‑guided pacing strategies to reduce symptom burden and post‑exertional malaise. https://longcovid.scripps.edu/wearable/ The Participant Center for the All of Us Research Program Building on a successful award from the National Institutes of Health (NIH) to bring precision medicine to diverse communities nationwide with digital devices and at‑home biospecimen collection. https://www.scripps.edu/science-and-medicine/translational-institute/translational-research/precision-medicine/index.html Except as otherwise indicated, the views, thoughts, and opinions expressed on this LinkedIn page belong solely to Moore Vogel Lab, and do not necessarily reflect those of Scripps Research, its employees, collaborators or affiliates.